Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
Submitted by
admin
on April 7, 2016 - 9:49am
Source:
FDA Law Blog
News Tags:
FDA
biosimilars
JNJ
Remicade
Inflectra
Pfizer
Celltrion
Headline:
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus